Credits: Canva
An experimental treatment happens to be the solution to delay Alzheimer's symptoms in some people. These people are the ones who are genetically destined to get the disease in their 40s or 50s. These new findings form ongoing research has now been caught up in Trump administration funding delas. The early results of the study has been published on Wednesday and the participants too are worried that politics could cut their access to a possible lifeline.
One of the participants had said, "It is still a study but it has given me an extension to my life that I never banked on having." The participant is named Jake Henrichs, form New York City, who is 50 years old. He is one of them to be treated in that study for more than a decade now and has remained symptom-free despite inheriting an Alzheimer's-causing gene that had killed his father and brother around the same age.
Two drugs which can modestly slow down early-stage Alzheimer's are sold in the United States. These drugs clear the brain of one of its hallmarks, a sticky gunk-like part called the amyloid. However, there have not been any hints that removing amyloid far earlier, way many years before the first symptoms appear, may postpone the disease.
The research is led by Washington University in St Louis, which involved families that passed down rare gene mutation as participants. This meant it was almost guaranteed that they will develop symptoms at the same age their affected relatives did.
The new findings is based on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset. The study is published in the journal Lancet Neurology.
Washington University's Dr Randall Bateman, who directs the Dominantly Inherited Alzheimer's Network of studies involving families with these rare genes says, "What we want to determine over the next five years is how strong is the protection. Will they ever get the symptoms of Alzheimer’s disease if we keep treating them?”
The researchers before though did not know what exactly caused Alzheimer's which affects nearly 7 million Americans, most of them in their later life. However, it is clear that these silent changes occur in the brain at least two decades before the first symptom shows up. The big contributor. At some point amyloid buildup can trigger a protein named tau that then starts to kill neurons, which can lead to cognitive decline.
Researchers are now thus studying the Tau-fighting drugs and are looking into other factors, like inflammation, brain's immune cells and certain virus.
The National Institute of Health (NIH) has expanded its focus as researchers have found more reasons for Alzheimer's. In 2013, the NIH's National Institute on Aging funded 14 trials of possible Alzheimer's drugs over a third targeting amyloid. By last fall, there were 68 drugs and 18% of them target amyloid. However, there are scientists too who think that amyloid is not everything and their is way more in the brain tissue, immune cells, and more which can be studied.
Credit: iStock
NASA scientists warn that the developing 2026–27 El Niño could rival or surpass the powerful 1997–98 event, which triggered severe droughts, fires and flooding worldwide.
The new findings amid climate deliberations taking place at the COP31 in Turkiye.
Using 35 years of satellite observations, researchers are comparing the current event with previous strong El Niños. The climate phenomenon, marked by warmer-than-average sea-surface temperatures in the central and eastern equatorial Pacific, can disrupt weather patterns worldwide and raise global temperatures.
The 1997–98 and 2015–16 events were among the strongest on record, bringing fires to Indonesia and the Amazon, droughts in southern Africa, and heavy rainfall in Southern California.
Also read: El Niño Could Worsen Dengue, Malaria And Heat Illness: Why WHO Declared A Health Emergency
Satellite altimetry measures changes in ocean surface height, helping scientists track heat accumulation in the Pacific. Warmer seawater expands, raising sea levels.
"What's unique about altimetry is that we have a 35-year record from nearly identical satellites flying almost the same ground track, with each mission overlapping the next," said Josh Willis, project scientist for sea level missions at NASA's Jet Propulsion Laboratory (JPL). "That lets us look back in time and compare this El Niño to what happened in 1997. And right now, this one is on track to be even bigger."
NASA's October measurements show similarities between the two events, including lower sea levels in the western Pacific, higher levels in the east and unusually warm water extending towards South America.
These patterns raise the possibility of similar weather effects, including substantial rainfall across California and the southern United States this winter.
Read More: Climate Crisis Is A Health Crisis: Just 6 Actions Could Save 1.6 Million Lives, Says WHO
NOAA's October 8 outlook estimated an 83% chance of strong to very strong El Niño conditions during the first three months of 2027.
On November 12, its Climate Prediction Center classified the event as "very strong", the highest of four intensity categories. Only three other events since 1950 have reached this level: 1982–83, 1997–98 and 2015–16.
However, El Niño's effects vary by region and do not guarantee the same weather extremes everywhere.
The World Meteorological Organization (WMO) warns that El Niño could amplify climate change-related health risks, including:
A World Food Programme (WFP) analysis published in October projected that El Niño could push 49 million additional people into acute food insecurity by the end of 2027, taking the global total from 225 million to 274 million.
At least 45 countries could experience worsening food insecurity, particularly communities dependent on rain-fed agriculture. WFP warns that the effects could persist through 2027 and into early 2028.
Credit: iStock
Air pollution is emerging as an important risk factor for lung cancer in India, with more young people and women who have never smoked being diagnosed with the disease, said Dr Abhishek Shankar, Associate Professor of Radiation Oncology at the All India Institute of Medical Sciences (AIIMS).
Speaking to HealthandMe, Dr Abhishek said nearly 50% of lung cancer cases are now unrelated to smoking, marking a shift from the earlier pattern, when more than 90% of cases were associated with smoking.
“So, now we see that nearly 50% lung cancer cases are not related to smoking, otherwise it was more than 90% related to smoking,” he said.
Also read: 91% Of Indian Studies Spanning 50 Years Link Air Pollution To Diabetes, Heart Disease And Cancer
Lung cancer has traditionally been associated with older male smokers. However, Dr Abhishek said he is seeing more younger people and women who have never smoked being diagnosed with the disease.
He believes air pollution could be contributing to this changing pattern.
“Now the air pollution is emerging as a risk factor and when we have more number of younger people and women who never smoke, never been exposed to any kind of, you know, second or third smoke is now coming with lung cancer.”
“The answer is very simple that air pollution has a lot much to do in terms of lung cancer in India,” Dr Abhishek said.
According to the World Health Organization (WHO), 99% of the global population breathes air that exceeds its guideline limits and contains high levels of pollutants. Low- and middle-income countries face the highest exposures.
The International Agency for Research on Cancer (IARC) classified outdoor air pollution as a Group 1 carcinogen in 2013, identifying lung cancer as one of the cancers associated with exposure.
Delhi's air quality has deteriorated sharply in recent weeks following Diwali. PM2.5 concentrations in several parts of the capital exceeded 66 times the WHO's recommended 24-hour guideline.
Long-term exposure to fine particulate matter is also a concern for children, as it can impair lung development and affect the maximum lung capacity they attain in adulthood. PM2.5's tiny particles can penetrate deep into the lungs.
Dr Abhishek pointed to research examining the relationship between particulate matter and cancer.
“Now, there are studies about the causal relationship between air pollution and lung cancer, particularly PM 2.5.”
He added that researchers have also investigated the association between different air pollutants and cancer.
“So, there are many cancers which have been studied in reference to different components of AQI, primarily the PM 2.5, PM 10 and I think they have been associated with cancer.”
Researchers are also investigating whether specific biomarkers can help identify people more susceptible to pollution-related lung cancer.
“At the same time, we are just talking about the PM 2.5 exposure-based biomarkers; what are the, you know, unique biomarkers that are expressed only in PM 2.5 exposure-based lung cancer, and we want to identify the susceptible lung cancer population women in those cohorts.”
Read More: Is India's Toxic Air Adding To Its Diabetes Crisis? What Experts Say
Dr Abhishek advised people to avoid going outdoors unless necessary during periods of severe pollution. However, he acknowledged that staying indoors is not always practical, particularly for those who need to commute to work.
He recommended wearing N95 masks to reduce exposure to fine particulate matter.
“N95 is useful. This is said to reduce exposure to the, you know, fine particles even.”
He also highlighted the use of indoor air purifiers, which can improve indoor air quality and make breathing easier. However, he noted that more research is needed to establish whether these measures reduce the risk of acute and chronic diseases.
Dr Abhishek is involved in two studies examining air pollution, lung cancer risk and screening in India.
The AIR CARE study will investigate how different components of PM2.5 contribute to lung cancer, how pollution interacts with other risk factors such as smoking, and whether exposure-based risk assessment and biomarkers can help identify high-risk groups.
The second, the Indian Lung Screening Trial, will involve around 10 centres across the country. It will assess lung cancer screening among people aged 50–80 with a smoking history of at least 20 pack-years.
The trial aims to generate evidence on lung cancer screening in the Indian population, building on findings from international studies. Dr Abhishek said initial trends from both studies are expected by the end of next year.
Credit: AI-generated image
A simple test done with a dissolvable capsule and a tiny sponge is being proposed to be included in standard use to identify people at risk of oesophageal cancer. This could reduce the need for invasive tests.
The technology, known as the ‘sponge on a string’ test, is being considered for widespread use across England's National Health Service (NHS) under new recommendations.
The UK's National Institute for Health and Care Excellence (NICE) has recommended two capsule sponge tests, Cytosponge and EndoSign, for NHS deployment. The tests can be performed in GP surgeries, pharmacies and community diagnostic centres without needing sedation.
The development marks a significant step as oesophageal cancer is often diagnosed at an advanced stage when treatment becomes challenging. More than 9,000 people are diagnosed with that cancer in the UK every year.
Also read: Microplastics May Promote The Growth Of One Of The Deadliest Cancers: Study
The test is done by having the patient swallow a small capsule attached to a thin string. Once it reaches the stomach, the capsule dissolves and releases a compressed sponge.
After approximately five to seven minutes, a healthcare professional gently pulls the sponge back through the mouth with the help of the string. As it travels upwards through the oesophagus, it gathers the cells from the lining of the food pipe. These samples are then sent to a laboratory for analysis.
The test takes around seven minutes and does not require sedation. Unlike an endoscopy, it does not involve passing a camera through the throat to examine the oesophagus directly.
The cells that are collected are examined for Barrett's oesophagus, a condition in which the cells along the lining of the food pipe undergoes changes related to prolonged exposure to stomach acid.
Between one and two adults per 100 is believed to have Barrett's oesophagus. Even though most won't go on to develop cancer, the demand of endoscopy to rule out cancer risk remains high.
Also read: Ivonescimab: Why Did US FDA Reject China's Promising Lung Cancer Drug?
Barrett's oesophagus is commonly linked to long-term gastro-oesophageal reflux in which stomach acid repeatedly flows back into the oesophagus.
Over time, this can damage the lining and cause alterations in the cells. In some people, these changes can progress to dysplasia, where cells become increasingly abnormal and eventually turn into oesophageal cancer.
The capsule sponge tests are intended to help identify people with Barrett's oesophagus who may need further investigation.
The proposed NHS recommendations are meant for people with chronic acid reflux or indigestion. Reflux is caused due to a weak sphincter at the bottom of the oesophagus, where it meets the stomach. It may keep allowing the stomach acids to flow the wrong way. Common symptoms of acid reflux include:
Professor Jonathan Benger, chief executive of NICE, said, “Capsule sponge tests offer a quick and less invasive way to detect concerning changes associated with oesophageal cancer or Barrett's oesophagus, helping to identify people who should go on to have further tests and treatment.”
Professor Peter Johnson, national clinical director for cancer at NHS England, said, “Many people have acid reflux, and having an easier way to check for changes in the lining of the oesophagus can make a big difference for patients – reducing the need for more complicated endoscopy tests and helping the NHS free up resources to find cancers at an earlier stage.”
© $2026 Times Horizon Private Limited